Company Filing History:
1 out of 93 
1 out of 94 
Years Active: 2015
Title: Carole Lamy: Innovator in Anti-Cancer Research
Introduction
Carole Lamy is a notable inventor based in Montigny le Bretonneux, France. She has made significant contributions to the field of anti-cancer research through her innovative work on phenazine derivatives. Her research focuses on developing compounds that can serve as anti-angiogenic and anti-tumor agents.
Latest Patents
Carole Lamy holds a patent for "Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agents." This patent describes novel phenazine derivatives that can be utilized in the treatment of cancer. The compounds disclosed in her patent have the potential to inhibit tumor growth and angiogenesis, making them valuable in cancer therapy.
Career Highlights
Throughout her career, Carole Lamy has worked with prestigious institutions, including Université Catholique de Louvain and Université Libre de Bruxelles. Her research has garnered attention for its innovative approach to combating cancer through chemical compounds.
Collaborations
Carole has collaborated with esteemed colleagues such as Olivier Feron and Olivier Riant. These partnerships have contributed to the advancement of her research and the development of her patented compounds.
Conclusion
Carole Lamy's work in the field of anti-cancer research exemplifies the impact of innovative thinking in medicine. Her patented compounds hold promise for future cancer treatments, showcasing her dedication to improving health outcomes.